Email Sign Up
  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • ASX Announcements
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Annual Reports
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • ASX Announcements
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Annual Reports
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Home > Media Centre > Media Coverage > media-coverage > Mergermarket “Anatara Lifesciences seeks deals to bolster human health”

Mergermarket “Anatara Lifesciences seeks deals to bolster human health”

21 JAN 2019 MERGERMARKET
Louise Weihart in Sydney

Anatara Lifesciences [ASX:ANR], an Australian developer of treatments for gastro-intestinal conditions with unmet medical need, is actively seeking deals to bolster its gastro-intestinal pipeline as it moves its focus to human health, said new Chief Executive Officer Steven Lydeamore.

For the full article, please click here –
190121 – Mergermarket – Anatara Lifesciences seeks deals to bolster human health

  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • ASX Announcements
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Annual Reports
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Email Sign Up
© 2023 Anatara Lifesciences Ltd | Privacy